Mailbox: The vaccine dilemma – more questions herd than answers
While Covid-19 vaccines certainly appear to make a contribution, maybe the primary driver here is good old herd immunity β which costs nothing.
While Covid-19 vaccines certainly appear to make a contribution, maybe the primary driver here is good old herd immunity β which costs nothing.
The BioVac Institute plans to manufacture a Covid-19 vaccine as a stepping stone toward developing an inoculation export industry in SA, reports Bloomberg.
‘South Africa paused the vaccineβs rollout after some preliminary data from the study was released last month’, according to Bloomberg.
Reports on Covid-19 related procurement and media coverage have all have flagged opacity and corruption on a wide scale, writes Geo Quinot.
To obtain herd immunity, SA is aiming to vaccinate 67% of the population – 40m people – by the end of 2021, says Veronica Ueckermann.
BizNews founder Alec hogg shares his rational perspective on Yuval Harari, an israeli author and historian who has shared insights on the pandemic.
With the rate of Covid-19 infections plummeting, President Cyril Ramaphosa has announced the lifting of lockdown restrictions from level 3 to level 1.
‘If you still want to join us at the BizNews Investment Conference from the 16th-19th of March, (R7 500 per delegate) please act soonest’, says Alec Hogg.
‘Interest rates are at record lows assisted by unprecedented money creation by pandemic-panicked governments’, writes BizNews founder Alec Hogg.
The SA military has illegally imported a drug which is supposedly an effective treatment for Covid-19 and wants to run a local trial.